Cargando…

Retrospective, multicenter study of surgical treatment for carotid body tumors with or without preoperative embolization

BACKGROUND: Carotid body tumor (CBT) is the most common head and neck paraganglioma. Whether preoperative embolization benefits CBT patients who will receive surgical resection is still controversial. METHODS: In this multi-center retrospective study, we collected data from patients with CBT who rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Tonglei, Pu, Jiaxi, Tang, Hanfei, Yang, Shaofei, Dong, Dandan, Lu, Minhao, Wei, Xiaolong, Yang, Guanghua, Zhao, Bin, Guo, Daqiao, Tang, Xiao, Zhao, Zhiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018181/
https://www.ncbi.nlm.nih.gov/pubmed/36937387
http://dx.doi.org/10.3389/fonc.2023.1123430
_version_ 1784907758408040448
author Han, Tonglei
Pu, Jiaxi
Tang, Hanfei
Yang, Shaofei
Dong, Dandan
Lu, Minhao
Wei, Xiaolong
Yang, Guanghua
Zhao, Bin
Guo, Daqiao
Tang, Xiao
Zhao, Zhiqing
author_facet Han, Tonglei
Pu, Jiaxi
Tang, Hanfei
Yang, Shaofei
Dong, Dandan
Lu, Minhao
Wei, Xiaolong
Yang, Guanghua
Zhao, Bin
Guo, Daqiao
Tang, Xiao
Zhao, Zhiqing
author_sort Han, Tonglei
collection PubMed
description BACKGROUND: Carotid body tumor (CBT) is the most common head and neck paraganglioma. Whether preoperative embolization benefits CBT patients who will receive surgical resection is still controversial. METHODS: In this multi-center retrospective study, we collected data from patients with CBT who received surgical treatment without (group A) or with preoperative embolization (group B) from 2011 to 2019. The primary outcome was the rate of death or stroke after 3 years of follow-up. The secondary outcomes of the study were length of operation (LOO), intraoperative blood loss (IBL), length of stay (LOS), rate of recurrence, and rate of cranial nerve (CN) injuries. Descriptive statistics were used to analyze the demographics, clinical characteristics, complications, and follow-up results of the patients. RESULTS: Between January 2011 and October 2019, 261 consecutive patients (107 male and 154 female) entered analysis. After 3 years of follow-up, no patient died in both groups. Only three patients with stroke were detected: 2/226 (0.9%) in group A vs. 1/35 (2.9%) in group B (p = .308). The LOO in group A was 132.6 ± 64.6 min compared with 152.9 ± 40.4 min in group B (p = .072). IBL in group A was 375.4 ± 497.8 ml compared with 448.0 ± 270.8 ml in group B (p = .400). LOS in group A was 8.3 ± 2.0 days compared with 7.4 ± 1.7 days in group B (p = .016). Seventy-two CN injuries were detected: 65/226 (28.8%) in group A vs. 7/35 (20.0%) in group B (p = .281). There were 65 temporary CN injuries (59 in group A vs. 6 in group B) (p = .254) and seven permanent CN injuries (6 in group A vs. 1 in group B) (p = .945). Three most frequently injured cranial nerves were the pharyngeal branch and superior laryngeal nerve (12.3%), recurrent laryngeal nerve (7.7%) and vagus nerve (7.3%). CONCLUSION: There was insufficient evidence to support the efficacy of preoperative embolization. CBT resection alone had a similar rate of stoke, recurrence, and CN injuries when compared with CBT resection with preoperative arterial embolization. Meanwhile, CBT resection alone did not increase LOO and IBL.
format Online
Article
Text
id pubmed-10018181
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100181812023-03-17 Retrospective, multicenter study of surgical treatment for carotid body tumors with or without preoperative embolization Han, Tonglei Pu, Jiaxi Tang, Hanfei Yang, Shaofei Dong, Dandan Lu, Minhao Wei, Xiaolong Yang, Guanghua Zhao, Bin Guo, Daqiao Tang, Xiao Zhao, Zhiqing Front Oncol Oncology BACKGROUND: Carotid body tumor (CBT) is the most common head and neck paraganglioma. Whether preoperative embolization benefits CBT patients who will receive surgical resection is still controversial. METHODS: In this multi-center retrospective study, we collected data from patients with CBT who received surgical treatment without (group A) or with preoperative embolization (group B) from 2011 to 2019. The primary outcome was the rate of death or stroke after 3 years of follow-up. The secondary outcomes of the study were length of operation (LOO), intraoperative blood loss (IBL), length of stay (LOS), rate of recurrence, and rate of cranial nerve (CN) injuries. Descriptive statistics were used to analyze the demographics, clinical characteristics, complications, and follow-up results of the patients. RESULTS: Between January 2011 and October 2019, 261 consecutive patients (107 male and 154 female) entered analysis. After 3 years of follow-up, no patient died in both groups. Only three patients with stroke were detected: 2/226 (0.9%) in group A vs. 1/35 (2.9%) in group B (p = .308). The LOO in group A was 132.6 ± 64.6 min compared with 152.9 ± 40.4 min in group B (p = .072). IBL in group A was 375.4 ± 497.8 ml compared with 448.0 ± 270.8 ml in group B (p = .400). LOS in group A was 8.3 ± 2.0 days compared with 7.4 ± 1.7 days in group B (p = .016). Seventy-two CN injuries were detected: 65/226 (28.8%) in group A vs. 7/35 (20.0%) in group B (p = .281). There were 65 temporary CN injuries (59 in group A vs. 6 in group B) (p = .254) and seven permanent CN injuries (6 in group A vs. 1 in group B) (p = .945). Three most frequently injured cranial nerves were the pharyngeal branch and superior laryngeal nerve (12.3%), recurrent laryngeal nerve (7.7%) and vagus nerve (7.3%). CONCLUSION: There was insufficient evidence to support the efficacy of preoperative embolization. CBT resection alone had a similar rate of stoke, recurrence, and CN injuries when compared with CBT resection with preoperative arterial embolization. Meanwhile, CBT resection alone did not increase LOO and IBL. Frontiers Media S.A. 2023-03-02 /pmc/articles/PMC10018181/ /pubmed/36937387 http://dx.doi.org/10.3389/fonc.2023.1123430 Text en Copyright © 2023 Han, Pu, Tang, Yang, Dong, Lu, Wei, Yang, Zhao, Guo, Tang and Zhao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Han, Tonglei
Pu, Jiaxi
Tang, Hanfei
Yang, Shaofei
Dong, Dandan
Lu, Minhao
Wei, Xiaolong
Yang, Guanghua
Zhao, Bin
Guo, Daqiao
Tang, Xiao
Zhao, Zhiqing
Retrospective, multicenter study of surgical treatment for carotid body tumors with or without preoperative embolization
title Retrospective, multicenter study of surgical treatment for carotid body tumors with or without preoperative embolization
title_full Retrospective, multicenter study of surgical treatment for carotid body tumors with or without preoperative embolization
title_fullStr Retrospective, multicenter study of surgical treatment for carotid body tumors with or without preoperative embolization
title_full_unstemmed Retrospective, multicenter study of surgical treatment for carotid body tumors with or without preoperative embolization
title_short Retrospective, multicenter study of surgical treatment for carotid body tumors with or without preoperative embolization
title_sort retrospective, multicenter study of surgical treatment for carotid body tumors with or without preoperative embolization
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018181/
https://www.ncbi.nlm.nih.gov/pubmed/36937387
http://dx.doi.org/10.3389/fonc.2023.1123430
work_keys_str_mv AT hantonglei retrospectivemulticenterstudyofsurgicaltreatmentforcarotidbodytumorswithorwithoutpreoperativeembolization
AT pujiaxi retrospectivemulticenterstudyofsurgicaltreatmentforcarotidbodytumorswithorwithoutpreoperativeembolization
AT tanghanfei retrospectivemulticenterstudyofsurgicaltreatmentforcarotidbodytumorswithorwithoutpreoperativeembolization
AT yangshaofei retrospectivemulticenterstudyofsurgicaltreatmentforcarotidbodytumorswithorwithoutpreoperativeembolization
AT dongdandan retrospectivemulticenterstudyofsurgicaltreatmentforcarotidbodytumorswithorwithoutpreoperativeembolization
AT luminhao retrospectivemulticenterstudyofsurgicaltreatmentforcarotidbodytumorswithorwithoutpreoperativeembolization
AT weixiaolong retrospectivemulticenterstudyofsurgicaltreatmentforcarotidbodytumorswithorwithoutpreoperativeembolization
AT yangguanghua retrospectivemulticenterstudyofsurgicaltreatmentforcarotidbodytumorswithorwithoutpreoperativeembolization
AT zhaobin retrospectivemulticenterstudyofsurgicaltreatmentforcarotidbodytumorswithorwithoutpreoperativeembolization
AT guodaqiao retrospectivemulticenterstudyofsurgicaltreatmentforcarotidbodytumorswithorwithoutpreoperativeembolization
AT tangxiao retrospectivemulticenterstudyofsurgicaltreatmentforcarotidbodytumorswithorwithoutpreoperativeembolization
AT zhaozhiqing retrospectivemulticenterstudyofsurgicaltreatmentforcarotidbodytumorswithorwithoutpreoperativeembolization